🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tobias Wertheimer

University of Freiburg

ORCID: 0000-0002-8480-7391

Also affiliated with University Medical Center Freiburg

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation”.

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

Blood(2022)10.1182/blood.2022016082

N/A

0DataRank · unranked

55 citations

Dominik Schmidt, Theresa Lowinus, Jeongmin Ryoo, Elaine-Pashupati Dopfer, Nicolás Gonzalo Núñez +38 more

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0898

N/A

0DataRank · unranked

29 citations

Sophie Giesler, Stefan Richtsfeld, Sara Costa-Pereira, Lukas Rindlisbacher, Tobias Wertheimer +17 more

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice

Journal of Clinical Investigation(2024)10.1172/jci177460

N/A

0DataRank · unranked

19 citations

Lukas M. Braun, Karen O. Dixon, Melissa Zwick, Helena Engel, Alina Hartmann +37 more